1. Home
  2. PKE vs ALDX Comparison

PKE vs ALDX Comparison

Compare PKE & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$30.13

Market Cap

680.4M

Sector

Industrials

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

88.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
ALDX
Founded
1954
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.4M
88.1M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
PKE
ALDX
Price
$30.13
$1.36
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
199.7K
634.6K
Earning Date
05-15-2026
05-01-2026
Dividend Yield
1.53%
N/A
EPS Growth
93.10
40.43
EPS
0.17
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$179.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.25
$1.07
52 Week High
$39.86
$5.93

Technical Indicators

Market Signals
Indicator
PKE
ALDX
Relative Strength Index (RSI) 36.84 39.45
Support Level $23.29 $1.33
Resistance Level $35.94 $1.58
Average True Range (ATR) 1.20 0.07
MACD -0.05 -0.01
Stochastic Oscillator 10.22 15.91

Price Performance

Historical Comparison
PKE
ALDX

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: